"Level of exports of generic drugs has grown up dramatically in recent years and correspondingly we have inspected more. When the exports from here grow up there will be more checks because obviously checks are part of approval process," Deputy Commissioner for Global Regulatory Operations and Policy USFDA Howard Sklamberg told reporters here.
"They (checks) are part of what we call surveillance system. And when we find something, we take appropriate action," he said.
The USFDA members are here to participate in the three-day World Spices Congress held by Spices Board of India.
In response to a question on action against big Indian generic pharma companies, Sklamberg said, "We apply same standards of inspecting at all levels like between the licensed drug manufacturing companies and generic drug manufacturing companies. The standards are same across all geographies".
The USFDA had taken action against companies like Sun Pharma last year and earlier Ranbaxy among other Indian drug companies.
Speaking about food exports from India to the US, he said that the highest exports is of sea food, then comes spices and the third is rice.
"We have introduced a new act called Food Safety Modernisation Act, and under it instead of just working on regulatory aspects, we work at all level with stakeholders like food manufacturers to exporters who export to the US," he added.
According to Sklamberg, they are here to explain this to the delegates of World Spices Congress as Indian spices export to the US is substantially.
USFDA team members had also met Gujarat State Food and Drug Administration yesterday to know about how it functions.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)